Société de Therapeutique Marocaine S.A. (CBSE: SOT)

Market Cap	6.83B
Revenue (ttm)	2.63B
Net Income (ttm)	274.42M
Shares Out	7.20M
EPS (ttm)	38.10
PE Ratio	24.34
Forward PE	24.43
Dividend	17.00 (1.79%)
Ex-Dividend Date	Jun 21, 2024

Volume	28
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	881.00 - 1,075.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 31, 2024

About SOT

Société de Therapeutique Marocaine S.A., a pharmaceutical company, engages in the manufacturing and sale of medicines in Morocco. It offers products in various therapeutic areas, including allergology, oncology, cardiology, dental, dermatology, endocrinology, gastroenterology, gynecology, ophthalmology, ENT, pediatric, pulmonology, reanimation, rheumatology, central nervous system (CNS), and urology, as well as antibiotics and other generic drugs. The company also provides its products in various forms, such as tablets, capsules, pouches, syrup...

• Industry: Pharmaceutical Preparations
• Founded: 1976
• Employees: 1,275
• Stock Exchange: Casablanca Stock Exchange
• Ticker Symbol: SOT

Financial Performance

In 2023, SOT's revenue was 2.49 billion, an increase of 8.00% compared to the previous year's 2.30 billion. Earnings were 262.76 million, a decrease of -1.45%.